Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.
about
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyMultistage vector (MSV) therapeutics.Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell responsePolymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.Post-nano strategies for drug delivery: Multistage porous silicon microvectors.A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.Enzyme-responsive multistage vector for drug delivery to tumor tissue.Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8+ T Cell Responses.Active diffusion of nanoparticles of maternal origin within the embryonic brain.Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination.Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.
P2860
Q26782566-A4BBDB80-B2C6-4A16-B809-1E98D4EF337CQ36307634-FFBC5465-90B4-4FFD-B8FB-49789E274AEBQ36356773-3A20D71D-D3D0-495F-9BDA-2CA60ED6DB4BQ37167802-309D7FF0-9B57-4904-8346-4497AF274FF3Q38962203-573FF539-2726-440A-9C09-5E20AF75867CQ39410383-0F0DC9C9-9CF5-43BE-82DC-C519FDCA0DFDQ41112245-454C92DC-7851-413E-A6C1-F85A7539F8C0Q42695589-F6C57779-3BC5-4ED3-9070-9D4EA34B8D0AQ48154385-10114AE8-5B62-4F9D-9402-19CC16BC2185Q48516344-6EA9CFBF-23E5-4285-A254-B9BF44A6BE5BQ50080885-1E6BC79B-05A9-4C46-B78E-98A9FB60F2D3Q50426810-BBF6E764-86D8-4CA1-B2D7-023487DB4088Q50454256-22D72F89-3102-4456-A3AA-41A68A5627DBQ51068276-11FC289B-1B38-47DF-814B-109EDC2B75F1
P2860
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Porous silicon microparticle p ...... ng type I interferon response.
@ast
Porous silicon microparticle p ...... ng type I interferon response.
@en
type
label
Porous silicon microparticle p ...... ng type I interferon response.
@ast
Porous silicon microparticle p ...... ng type I interferon response.
@en
prefLabel
Porous silicon microparticle p ...... ng type I interferon response.
@ast
Porous silicon microparticle p ...... ng type I interferon response.
@en
P2093
P2860
P1433
P1476
Porous silicon microparticle p ...... ng type I interferon response.
@en
P2093
Chaofeng Mu
David B Corry
Haifa Shen
Hui-Ying Tung
Jorge Enrique Tovar Perez
Maria L Guevara
Mauro Ferrari
Rong-Fu Wang
P2860
P304
P356
10.1016/J.CELREP.2015.04.009
P577
2015-04-30T00:00:00Z